Portfolio company
Phagenesis
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
Phagenesis develops pharyngeal electrical stimulation systems to treat neurogenic dysphagia for patients with brain injuries, stroke or neurological conditions and their healthcare providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Synapse Biomedical
The company manufactures neurostimulation systems to treat diaphragm dysfunction and facilitate stroke recovery for patients with spinal cord injuries, ALS or paralysis.
MicroTransponder
This company develops implanted vagus nerve stimulation devices to help chronic stroke survivors regain hand and arm function during rehabilitation.
BrainsGate
This medical device company develops implantable neurostimulation systems that increase cerebral blood flow to treat acute ischemic stroke and central nervous system diseases.
Neuros Medical
This company produces implantable nerve stimulation systems for adult amputees to manage chronic phantom and residual lower limb pain.
BrainQ
This company develops non-invasive, AI-guided electromagnetic neurorehabilitation devices and cloud-based monitoring platforms for stroke survivors and patients with neurological disorders to support recovery.
Pharaoh Neuro
This medical device company develops systems that filter cerebrospinal fluid to treat haemorrhage patients and cranial access ports for neurosurgical procedures.
NeuroTronik
This medical technology company develops neurostimulation systems for clinicians to treat patients suffering from acute heart failure.
Neuromodulation
This company develops miniaturised peripheral nerve stimulation implants and wireless power systems to treat patients suffering from chronic neuropathic pain.
